Search results for "Cardiology"
Evidence shifting for cardiac drugs with insect allergies
The cardiovascular benefits of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors must be weighed against anaphylaxis risk in patients with allergy.
https://immattersacp.org/archives/2022/04/evidence-shifting-for-cardiac-drugs-with-insect-allergies.htm
1 Apr 2022
Latest research shows impact of COVID-19 on other health care
Hospitalizations for stroke and myocardial infarction, ED visits, cancer diagnoses, and trials for conditions other than COVID-19 all dropped during the pandemic, recent studies show.
https://immattersacp.org/weekly/archives/2020/08/11/1.htm
11 Aug 2020
MKSAP quiz: Evaluation during a routine examination
A 59-year-old man is evaluated during a routine examination. He feels well and has no symptoms. Medical history is significant for hypertension. On physical examination, the patient is afebrile, blood pressure is 122/74 mm Hg, and pulse rate is 76/min. Cardiac examination is unremarkable. What is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2019/12/17/3.htm
17 Dec 2019
Factoring drug costs into diabetes decisions
A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
https://immattersacp.org/archives/2022/05/factoring-drug-costs-into-diabetes-decisions.htm
1 May 2022
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a new trial, tocilizumab had mixed results, and remdesivir got full approval, among other COVID-19 news.
https://immattersacp.org/weekly/archives/2020/10/27/1.htm
27 Oct 2020
ACP urges balance of benefits, harms, patient preferences for hypertension treatment
The commentary in Annals of Internal Medicine discusses why ACP believes that the evidence does not strongly support pharmacologic initiation and treatment targets of less than 130/80 mm Hg in a broad population of older adults, among other issues.
https://immattersacp.org/weekly/archives/2018/01/23/2.htm
23 Jan 2018
Panel ponders postacute sequelae of COVID-19
The consequences of postacute sequelae of COVID-19 have led to research into this emerging condition.
https://immattersacp.org/archives/2021/07/panel-ponders-postacute-sequelae-of-covid-19.htm
1 Jul 2021
Polypill strategy may help improve outcomes, adherence in underserved populations
The researchers said that the observed reductions in systolic blood pressure and LDL cholesterol level were clinically and statistically significant and, if sustained, would lead to an estimated 25% reduction in cardiovascular event incidence.
https://immattersacp.org/weekly/archives/2019/09/24/2.htm
24 Sep 2019
NOACs recommended instead of warfarin for some afib patients, guideline states
An updated guideline on atrial fibrillation responds to new evidence, as well as the advent of new drugs and devices to treat the condition.
https://immattersacp.org/weekly/archives/2019/02/05/2.htm
5 Feb 2019
Reassurance on ACE inhibitors, ARBs and COVID-19; new rules, advice from CMS and CDC
Also, ACP launched a new interactive CME program to help practices start and sustain telemedicine programs, and an ACP webinar on March 30 will offer advice from the front lines for maintaining physician well-being during the pandemic.
https://immattersacp.org/weekly/archives/2020/03/24/1.htm
24 Mar 2020